# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-22-027121
Filing Date
2022-09-29
Accepted
2022-09-29 08:30:26
Documents
25
Period of Report
2022-09-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 42457
2 |  | ex99-1.htm | EX-99.1 | 12429
3 |  | ex99-1_001.jpg | GRAPHIC | 390764
4 |  | ex99-1_002.jpg | GRAPHIC | 151891
5 |  | ex99-1_003.jpg | GRAPHIC | 211063
6 |  | ex99-1_004.jpg | GRAPHIC | 340428
7 |  | ex99-1_005.jpg | GRAPHIC | 187974
8 |  | ex99-1_006.jpg | GRAPHIC | 153847
9 |  | ex99-1_007.jpg | GRAPHIC | 166868
10 |  | ex99-1_008.jpg | GRAPHIC | 166968
11 |  | ex99-1_009.jpg | GRAPHIC | 140608
12 |  | ex99-1_010.jpg | GRAPHIC | 126240
13 |  | ex99-1_011.jpg | GRAPHIC | 338467
14 |  | ex99-1_012.jpg | GRAPHIC | 287992
| Complete submission text file | 0001493152-22-027121.txt |  | 3897044

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
15 | INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | anix-20220928.xsd | EX-101.SCH | 3218
16 | INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | anix-20220928_lab.xml | EX-101.LAB | 34240
17 | INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | anix-20220928_pre.xml | EX-101.PRE | 22353
19 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3621

Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-37492 | Film No.: 221277780
SIC: 2834 Pharmaceutical Preparations